πŸ‡ΊπŸ‡Έ FDA
Patent

US 9957569

Recurrent gene fusions in prostate cancer

granted A61PA61P13/08A61P35/00

Quick answer

US patent 9957569 (Recurrent gene fusions in prostate cancer) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Apr 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue May 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61P, A61P13/08, A61P35/00